Coluracetam 135463-81-9 Coluracetam factory
Details:
our advantages:
1, high quality with competitive price:
1) standard:bp/usp/ep/enterprise standard
2) all purity≥99%
3) we are manufacturer and can provide high quality products with factory price.
2, fast and safe delivery
1) parcel can be sent out in 24 hours after payment.tracking number available
2) secure and discreet shipment.various transportation methods for your choice.
3) customs pass rate ≥99%
4) we have our own agent/remailer/distributor who can help us ship our products very fast and safe,
and we have stock in there for transferring.
3,we have clients throughout the world.
1) professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2) market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.
3) high quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.
product name | coluracetam |
cas no. | 135463-81-9 |
assay | ≥99% |
capacity | 50mt/year |
min.packing | 1gram |
application | pharmaceutical/pesticide intermediate |
standard | enterprise export |
manufacturer | kern Enterprises Co. LTD |
more information |
synonyms: n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide molecular formula: c19h23n3o3 molecular weight: 341.40 cas registry number: 135463-81-9 |
Product name:Coluracetam
Chemical name: N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide.
CAS:135463-81-9
Purity: 99%
Appearance: white crystalline powder
Package: 1kg/bag.
Description:
Coluracetam (BCI-540) is a nootropic drug of the racetam family.Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD).BrainCells Inc is currently out-licensing the drug for this purpose.It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.
Coluracetam enhances high-affinity choline uptake (HACU) which is the rate-limiting step of acetylcholine (ACh) synthesis, and is the only known choline uptake enhancer to currently exist. Studies have shown Coluracetam to improve learning impairment on a single oral dose given to rats which have been exposed to cholinergic neurotoxins. Subsequent studies have shown that it may induce long-lasting procognitive effects by changing the choline transporter regulation system.
Molecular Structure | Hazard Symbols | ||
Synonyms |
Molecular Structure of Coluracetam (CAS No.135463-81-9):
Molecular Formula: C19H23N3O3
Molecular Weight: 341.4042
CAS No: 135463-81-9
H bond acceptors: 6
H bond donors: 1
Freely Rotating Bonds: 3
Polar Surface Area: 66.65 Å2
Index of Refraction: 1.64
Molar Refractivity: 95.35 cm3
Molar Volume: 264.3 cm3
Surface Tension: 61 dyne/cm
Density: 1.291 g/cm3
Flash Point: 337.3 °C
Enthalpy of Vaporization: 93.72 kJ/mol
Boiling Point: 634.1 °C at 760 mmHg
Vapour Pressure: 5.54E-16 mmHg at 25°C
InChI: InChI=1/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23)
InChIKey: PSPGQHXMUKWNDI-UHFFFAOYAB
Std. InChI: InChI=1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23)
Std. InChIKey: PSPGQHXMUKWNDI-UHFFFAOYSA-N
IUPAC Name: N-(2,3-dimethyl-5,6,7,8- tetrahydrofuro[2,3-b] quinolin-4-yl)-2- (2-oxopyrrolidin-1-yl)acetamide
Classification Code: Nootropic Agent
As a nootropic drug of the racetam family, Coluracetam may have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.
Coluracetam (CAS No.135463-81-9), its synonyms are N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide ; 1-Pyrrolidineacetamide, 2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro[2,3-b]quinolin-4-yl)- .
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View